Alnylams commercial RNAi therapeutic products are ONPATTRO patisiran GIVLAARI givosiran OXLUMO lumasiran AMVUTTRA vutrisiran and Leqvio inclisiran being developed and comm ercialized by Alnylams partner Novartis